| pubmed-article:18098210 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18098210 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18098210 | lifeskim:mentions | umls-concept:C0020517 | lld:lifeskim |
| pubmed-article:18098210 | lifeskim:mentions | umls-concept:C1518923 | lld:lifeskim |
| pubmed-article:18098210 | lifeskim:mentions | umls-concept:C0017638 | lld:lifeskim |
| pubmed-article:18098210 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:18098210 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:18098210 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:18098210 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18098210 | pubmed:dateCreated | 2008-2-7 | lld:pubmed |
| pubmed-article:18098210 | pubmed:abstractText | Carboplatin-based regimens have demonstrated activity in pediatric patients with low-grade glioma (LGG). However, carboplatin hypersensitivity reaction (Cb HSR) represents a common and limiting factor for the continuation of therapy. | lld:pubmed |
| pubmed-article:18098210 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18098210 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18098210 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18098210 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18098210 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18098210 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18098210 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:18098210 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:SungLillianL | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:HukinJuliette... | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:ZelcerShaynaS | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:BouffetEricE | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:StrotherDougl... | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:JohnstonDonna... | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:SilvaMarianaM | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:OdameIsaacI | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:Lafay-CousinL... | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:CarretAnne-So... | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:MpofuChrisC | lld:pubmed |
| pubmed-article:18098210 | pubmed:author | pubmed-author:WilsonBeverly... | lld:pubmed |
| pubmed-article:18098210 | pubmed:copyrightInfo | Cancer 2008. (c) 2007 American Cancer Society. | lld:pubmed |
| pubmed-article:18098210 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18098210 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:18098210 | pubmed:volume | 112 | lld:pubmed |
| pubmed-article:18098210 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18098210 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18098210 | pubmed:pagination | 892-9 | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:meshHeading | pubmed-meshheading:18098210... | lld:pubmed |
| pubmed-article:18098210 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18098210 | pubmed:articleTitle | Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience. | lld:pubmed |
| pubmed-article:18098210 | pubmed:affiliation | Pediatric Brain Tumor Program, Hospital for Sick Children, Toronto, Ontario, Canada. lucie.lafay-cousin@calgaryhealthregion.ca | lld:pubmed |
| pubmed-article:18098210 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18098210 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18098210 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18098210 | lld:pubmed |
